The Cefoperazone–Sulbactam Combination: In Vitro Qualities Including Beta-Lactamase Stability, Antimicrobial Activity, and Interpretive Criteria for Disk Diffusion Tests-Reference-Cited by-同舟云学术

The Cefoperazone–Sulbactam Combination: In Vitro Qualities Including Beta-Lactamase Stability, Antimicrobial Activity, and Interpretive Criteria for Disk Diffusion Tests

Published:1985-10-01 Issue:4 Volume:84 Page:496-504
ISSN:1943-7722
Container-title:American Journal of Clinical Pathology
language:en
Short-container-title:

Author:

Jones Ronald N.¹,Barry Arthur L.¹,Thornsberry Clyde¹,Wilson Harold W.¹

Affiliation:

1. The Clinical Microbiology Institute, Tualatin, Oregon, and The Centers for Disease Control, Atlanta, Georgia

Publisher

Oxford University Press (OUP)

Subject

General Medicine

Link

http://academic.oup.com/ajcp/article-pdf/84/4/496/26433415/ajcpath84-0496.pdf

Cited by 20 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Durlobactam, a Broad-Spectrum Serine β-lactamase Inhibitor, Restores Sulbactam Activity AgainstAcinetobacterSpecies;Clinical Infectious Diseases;2023-05-01

2. Correlation Between Cefoperazone/Sulbactam MIC Values and Clinical Outcomes of Escherichia coli Bacteremia;Infectious Diseases and Therapy;2022-07-22

3. Cefoperazone-sulbactam and risk of coagulation disorders or bleeding: a retrospective cohort study;Expert Opinion on Drug Safety;2020-01-27

4. Comparison of antimicrobial efficacy of a fixed dose combination of ceftazidime + sulbactam with ceftazidime and sulbactam alone against five bacteria;Folia Microbiologica;2009-09

5. In vitro activities of various piperacillin and sulbactam combinations against bacterial pathogens isolated from Intensive Care Units in Taiwan: SMART 2004 programme data;International Journal of Antimicrobial Agents;2007-02